Literature DB >> 33692783

Hyperactive Behavior and Altered Brain Morphology in Adult Complement C3a Receptor Deficient Mice.

Andrea Pozo-Rodrigálvarez1, Roosa Ollaranta1, Jenny Skoog1, Milos Pekny2,3,4, Marcela Pekna1,3,4.   

Abstract

The C3a receptor (C3aR) is a seven trans-membrane domain G-protein coupled receptor with a range of immune modulatory functions. C3aR is activated by the third complement component (C3) activation derived peptide C3a and a neuropeptide TLQP-21. In the central nervous system (CNS), C3aR is expressed by neural progenitors, neurons as well as glial cells. The non-immune functions of C3aR in the adult CNS include regulation of basal neurogenesis, injury-induced neural plasticity, and modulation of glial cell activation. In the developing brain, C3aR and C3 have been shown to play a role in neural progenitor cell proliferation and neuronal migration with potential implications for autism spectrum disorder, and adult C3aR deficient (C3aR -/-) mice were reported to exhibit subtle deficit in recall memory. Here, we subjected 3 months old male C3aR -/- mice to a battery of behavioral tests and examined their brain morphology. We found that the C3aR -/- mice exhibit a short-term memory deficit and increased locomotor activity, but do not show any signs of autistic behavior as assessed by self-grooming behavior. We also found regional differences between the C3aR -/- and wild-type (WT) mice in the morphology of motor and somatosensory cortex, as well as amygdala and hippocampus. In summary, constitutive absence of C3aR signaling in mice leads to neurodevelopmental abnormalities that persist into adulthood and are associated with locomotive hyperactivity and altered cognitive functions.
Copyright © 2021 Pozo-Rodrigálvarez, Ollaranta, Skoog, Pekny and Pekna.

Entities:  

Keywords:  C3aR; attention deficit hyperactivity disorder; autism spectrum disorder; neurodevelopment; the complement system

Mesh:

Substances:

Year:  2021        PMID: 33692783      PMCID: PMC7937871          DOI: 10.3389/fimmu.2021.604812

Source DB:  PubMed          Journal:  Front Immunol        ISSN: 1664-3224            Impact factor:   7.561


  37 in total

1.  Expression of receptors for complement anaphylatoxins C3a and C5a following permanent focal cerebral ischemia in the mouse.

Authors:  J Van Beek; M Bernaudin; E Petit; P Gasque; A Nouvelot; E T MacKenzie; M Fontaine
Journal:  Exp Neurol       Date:  2000-01       Impact factor: 5.330

2.  Characterization of C3a and C5a receptors in rat cerebellar granule neurons during maturation. Neuroprotective effect of C5a against apoptotic cell death.

Authors:  Magalie Bénard; Bruno J Gonzalez; Marie-Thérèse Schouft; Anthony Falluel-Morel; David Vaudry; Philippe Chan; Hubert Vaudry; Marc Fontaine
Journal:  J Biol Chem       Date:  2004-08-02       Impact factor: 5.157

Review 3.  The role of the anaphylatoxins in health and disease.

Authors:  Andreas Klos; Andrea J Tenner; Kay-Ole Johswich; Rahasson R Ager; Edimara S Reis; Jörg Köhl
Journal:  Mol Immunol       Date:  2009-05-28       Impact factor: 4.407

Review 4.  Is the complement activation product C3a a proinflammatory molecule? Re-evaluating the evidence and the myth.

Authors:  Liam G Coulthard; Trent M Woodruff
Journal:  J Immunol       Date:  2015-04-15       Impact factor: 5.422

Review 5.  Regulation of neuronal migration, an emerging topic in autism spectrum disorders.

Authors:  Orly Reiner; Eyal Karzbrun; Aditya Kshirsagar; Kozo Kaibuchi
Journal:  J Neurochem       Date:  2015-11-13       Impact factor: 5.372

Review 6.  Neuroinflammation as a risk factor for attention deficit hyperactivity disorder.

Authors:  Geoffrey A Dunn; Joel T Nigg; Elinor L Sullivan
Journal:  Pharmacol Biochem Behav       Date:  2019-05-16       Impact factor: 3.533

Review 7.  Attention-deficit/hyperactivity disorder: a selective overview.

Authors:  Joseph Biederman
Journal:  Biol Psychiatry       Date:  2004-12-18       Impact factor: 13.382

Review 8.  Neurobiology of rodent self-grooming and its value for translational neuroscience.

Authors:  Allan V Kalueff; Adam Michael Stewart; Cai Song; Kent C Berridge; Ann M Graybiel; John C Fentress
Journal:  Nat Rev Neurosci       Date:  2015-12-17       Impact factor: 34.870

9.  Developmental activities of the complement pathway in migrating neurons.

Authors:  Anna Gorelik; Tamar Sapir; Rebecca Haffner-Krausz; Tsviya Olender; Trent M Woodruff; Orly Reiner
Journal:  Nat Commun       Date:  2017-05-02       Impact factor: 14.919

Review 10.  Complement System in Brain Architecture and Neurodevelopmental Disorders.

Authors:  Juliana Magdalon; Fernanda Mansur; André Luiz Teles E Silva; Vitor Abreu de Goes; Orly Reiner; Andréa Laurato Sertié
Journal:  Front Neurosci       Date:  2020-02-05       Impact factor: 4.677

View more
  5 in total

1.  Complement Component C3 Loss leads to Locomotor Deficits and Altered Cerebellar Internal Granule Cell In Vitro Synaptic Protein Expression in C57BL/6 Mice.

Authors:  Nicholas W DeKorver; Tammy R Chaudoin; Gang Zhao; Dong Wang; Jyothi Arikkath; Stephen J Bonasera
Journal:  Mol Neurobiol       Date:  2021-08-20       Impact factor: 5.590

Review 2.  Complement Dependent Synaptic Reorganisation During Critical Periods of Brain Development and Risk for Psychiatric Disorder.

Authors:  Laura J Westacott; Lawrence S Wilkinson
Journal:  Front Neurosci       Date:  2022-05-06       Impact factor: 5.152

Review 3.  Reactive Astrocytes in Central Nervous System Injury: Subgroup and Potential Therapy.

Authors:  GuiLian Yu; Ying Zhang; Bin Ning
Journal:  Front Cell Neurosci       Date:  2021-12-23       Impact factor: 5.505

4.  C3a Receptor Signaling Inhibits Neurodegeneration Induced by Neonatal Hypoxic-Ischemic Brain Injury.

Authors:  Andrea Pozo-Rodrigálvarez; YiXian Li; Anna Stokowska; Jingyun Wu; Verena Dehm; Hana Sourkova; Harry Steinbusch; Carina Mallard; Henrik Hagberg; Milos Pekny; Marcela Pekna
Journal:  Front Immunol       Date:  2021-12-17       Impact factor: 7.561

Review 5.  Targeting Complement C3a Receptor to Improve Outcome After Ischemic Brain Injury.

Authors:  Marcela Pekna; Anna Stokowska; Milos Pekny
Journal:  Neurochem Res       Date:  2021-08-11       Impact factor: 3.996

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.